Ulcerative colitis

August 3, 2018August 3, 2018

Pfizer’s Xeljanz Approved in EU for Adults with Moderate to Severe Ulcerative Colitis

News, Ulcerative colitis

The European Commission has approved Pfizer‘s Xeljanz (tofacitinib) for the treatment of adults with moderate to severe active ulcerative colitis (UC) who have failed to fully respond to other therapies. The ... Read more

August 11, 2017August 16, 2017

Ulcerative Colitis Investigational Therapy TD-1473 Shows Encouraging Results in Early Trial

News, Ulcerative colitis

Early data from a Phase 1b clinical trial show that the investigational therapy TD-1473 for patients with ulcerative colitis (UC) has demonstrated targeted action and effectiveness, according to the therapy’s ... Read more

August 7, 2017August 29, 2017

7 Famous Personalities With Ulcerative Colitis

Inflammatory bowel disease (IBD) can strike anyone at any time and being a celebrity does not make you immune. We’ve compiled a list of seven famous personalities who suffer from ulcerative colitis using ... Read more

July 24, 2017August 28, 2017

What Is Microscopic Colitis?

Microscopic colitis is a form of inflammatory bowel disease (IBD) that affects the colon and rectum (large bowel). There are two different forms of the condition — collagenous colitis and lymphocytic ... Read more

July 21, 2017August 18, 2017

Cannabosides Show Positive Results as Potential Colitis Treatment in Preclinical Studies

News, Ulcerative colitis

A new class of ingestible cannabinoid prodrugs known as cannabosides developed to treat colitis have shown positive results in preclinical studies, Vitality Biopharma has announced. Cannabosides are a modification of a novel class ... Read more

July 14, 2017August 29, 2017

FDA Considering Pfizer’s Rheumatoid Arthritis Therapy Xeljanz for Ulcerative Colitis, Too

News, Ulcerative colitis

U.S. regulators are considering extending their approval of Pfizer’s rheumatoid arthritis therapy Xeljanz to ulcerative colitis as well. That possibility surfaced when the Food and Drug Administration accepted Pfizer’s supplemental New Drug Application for Xeljanz ... Read more

July 13, 2017August 29, 2017

Innovate Seeks Orphan Drug Status for Pediatric Ulcerative Colitis Therapy Candidate INN-108

News, Ulcerative colitis

Innovate Biopharmaceuticals recently submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for its potential pediatric ulcerative colitis therapy, INN-108. The FDA issues orphan drug ... Read more

August 26, 2016August 26, 2016

Peptide-Based Oral Drugs for Bowel Diseases Closer to Development

Crohn's Disease, IBD News, News, Ulcerative colitis

University of Queensland‘s spin-off biotech company Protagonist Therapeutics is getting closer to developing peptide-based first-in-class oral drugs for treating inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC). The oral therapy has ... Read more

August 22, 2016August 22, 2016

Last Call for Abstracts for Inflammatory Bowel Diseases Meeting, AIBD 2016

Colon Cancer, Crohn's Disease, IBD News, News, Ulcerative colitis

Organizers of the Advances in Inflammatory Bowel Diseases (AIBD 2016) Conference announced that its final date for abstract submission is Sept. 13. AIBD is the Crohn’s & Colitis Foundation of America’s (CCFA) clinical research conference, and ... Read more

August 19, 2016August 19, 2016

Ginger Nanoparticles May Be Inexpensive, Nontoxic IBD Treatment, VA Researchers Say

Colon Cancer, Crohn's Disease, IBD News, News, Ulcerative colitis

A study by researchers at the Atlanta VA Medical Center revealed that nanoparticles derived from fresh ginger root may be an effective treatment for Crohn’s disease and ulcerative colitis. In ... Read more